Home GSK's breast cancer drug Tykerb fails in gastric cancer study
 

Keywords :   


GSK's breast cancer drug Tykerb fails in gastric cancer study

2013-06-03 14:37:51| Biotech - Topix.net

GlaxoSmithKline said on Monday that its breast cancer drug lapatinib in combination with chemotherapy did not improve survival rates for patients with gastric cancer compared to the use of chemotherapy alone.

Tags: study drug cancer fails

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
11.10Talks over 1bn UK port expansion ongoing after row
11.10Evonik Aligning Two Business Lines with New Growth Strategy
11.10BASF Awarded a Red Dot for its Unique Automotive Coating Concept
11.10Tropical Storm Leslie Graphics
11.10Tropical Storm Leslie Forecast Discussion Number 37
11.10Tropical Storm Leslie Wind Speed Probabilities Number 37
11.10Tropical Storm Leslie Forecast Advisory Number 37
11.10Tropical Storm Leslie Public Advisory Number 37
More »